← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Pazopanibhydrochlorid currently has availability issues reported in 3 European registers: Germany, Spain, Italy.
Shortage ATC L01EX03 · also listed as: Pazopanibhydrochlorid · PAZOPANIB · data refreshed 9 September 2026
As of 9 September 2026, 3 of the 9 tracked registers list current availability issues for Pazopanibhydrochlorid, covering 5 affected product presentations. The longest-running open report was filed in Germany on 2026-04-01 and has now been open for about 5 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-29; the earliest is 2026-09-15. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Germany reported first (2026-04-01), with Italy following roughly 4 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Pazopanibhydrochlorid is coded L01EX03 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Pazopanib Viatris 200 mg Filmtabletten + 1 more productsPazopanib Viatris 400 mg Filmtabletten | 2026-04-01 | 2026-09-15 | Sonstige Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage PAZOPANIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos + 1 more productsPAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 2026-05-20 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage PAZOPANIB ZENTIVA | 2026-08-31 | — | Problemi produttivi Alternatives: AIFA: an alternative treatment is available (ask your doctor). | register ↗ |
Every individual register entry for Pazopanibhydrochlorid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | PAZOPANIB ZENTIVA | Shortage | 2026-08-31 | — | Problemi produttivi |
| 🇪🇸 ES | PAZOPANIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, | Shortage | 2026-08-23 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 | Shortage | 2026-05-20 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | Pazopanib Viatris 200 mg Filmtabletten | Shortage | 2026-04-01 | 2026-09-15 | Sonstige |
| 🇩🇪 DE | Pazopanib Viatris 400 mg Filmtabletten | Shortage | 2026-04-01 | 2026-09-15 | Sonstige |
Yes. As of 9 September 2026, availability issues are reported in: Germany, Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-15 to 2026-09-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Pazopanibhydrochlorid: BfArM (Germany), AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pazopanibhydrochlorid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pazopanibhydrochlorid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pazopanibhydrochlorid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pazopanibhydrochlorid/">Pazopanibhydrochlorid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>